Skip to Content
Søk Menu

SABCS20: Circulating tumor cells can predict response in metastatic breast cancer

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Related

Hatem Azim

Using Fertility Options May be Safe for Patients with HR-positive Breast Cancer

/ Hatem Azim
BrystkreftSABCS23 Play the Video 10:10
Terry Mamounas

The Effectiveness of Regional Nodal Radiation in Patients with Breastcancer

/ Eleftherios (Terry) P. Mamounas
BrystkreftSABCS23 Play the Video 13:26

SABCS 2023: HR-Positive Breast Cancer Patients May Safely Use Fertility Options

/ BestPractice Nordic
BrystkreftSABCS23

SABCS 2023: Younger Postmenopausal Women May Safely Skip Adjuvant Radiotherapy

/ BestPractice Nordic
BrystkreftSABCS23

SABCS 2023: Neoadjuvant Chemotherapy: May Reduce Regional Nodal Irradiation in Breast Cancer Patients

/ BestPractice Nordic
BrystkreftSABCS23

SABCS 2023: Blood Hormone Levels: A Key to Effective Breast Cancer Prevention in Post-Menopausal Women

/ BestPractice Nordic
BrystkreftSABCS23

BestPractice Nordic is covering SABCS 2023

/ BestPractice Nordic
BrystkreftSABCS23
Hope Rugo

The Potential of Trodelvy® for Patients with HR+/HER2- Metastatic Breast Cancer Patients Treated with Trodelvy®

/ Hope S. Rugo
Brystkreft Play the Video 6:03
Elsebeth Lynge

Does breast density affect the risk of breast cancer?

/ Elsebeth Lynge
BrystkreftSABCS22 Play the Video 6:29
Back to top